New Issue: Credit Suisse prices $570,000 accelerated barrier notes on SPDR S&P Biotech

By Susanna Moon

Chicago, Sept. 9 – Credit Suisse AG, London Branch priced $570,000 of 0% accelerated barrier notes due Sept. 4, 2020 linked to the SPDR S&P Biotech exchange-traded fund, according to a 424B2 filing with the Securities and Exchange Commission.

If the fund finishes at or above the initial level, the payout at maturity will be par plus 115% of the return.

If the fund falls by up to the 53.5% knock-in level, the payout will be par.

Otherwise, investors will be fully exposed to any losses.

Credit Suisse Securities (USA) LLC is the underwriter.

Issuer:	Credit Suisse AG, London Branch
Issue:	Accelerated barrier notes
Underlying fund:	SPDR S&P Biotech ETF
Amount:	$570,000
Maturity:	Sept. 4, 2020
Coupon:	0%
Price:	Par
Payout at maturity:	If the fund gains, par plus 115% of return; if the fund falls by up to knock-in level, par; otherwise, full exposure to losses
Initial level:	$215.51
Knock-in level:	53.5% of initial level
Pricing date:	Sept. 1
Settlement date:	Sept. 4
Underwriter:	Credit Suisse Securities (USA) LLC
Fees:	0.8%
Cusip:	22546VKD7

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.